GPBAR1, FFA1, and GPR119 agonists induce motilin secretion. (A) Bulk RNA sequencing data showing transcripts per million (TPM) of fat and bile sensing receptors in MLN-Venus and negative cells, (BeD) Motilin secretion in response to indicated agonists (expressed as fold change versus basal condition measured in parallel). *p < 0.05, **p < 0.01, ***p < 0.001 by Welch's t-test, or Browne-Forsyth and Welch ANOVA with Dunnett's multiple comparisons (n ¼ 6e14 wells from 3 to 7 independent experiments), (E) Fura2 (340/380 nm) ratio in one representative MLN-Venus cell during perfusion of FFA1 agonist AM1638 (10 mM, pink), (F) Calcium signal across several cells, measured as fold change in maximal fura2 ratio, as in (E). ***p < 0.001 by one-sample test (n ¼ 77 cells from 7 independent experiments), (G) Action potentials evoked by incremental (þ2 pA) 500 ms current steps from 12 to 18 pA in the presence (blue) or absence (black) of GPBAR-A (3 mM). The dotted line at 0 mV represents the threshold used to count action potential spikes. The same axis scale is applied across all traces, and the current injection protocol applied is shown below voltage traces, (H) The number of action potentials recorded as in (G). *p < 0.05, **p < 0.01 by two-way ANOVA with Sidak's multiple comparisons (n ¼ 5 cells). Mean AE SEM presented.

GPBAR1, FFA1, and GPR119 agonists induce motilin secretion. (A) Bulk RNA sequencing data showing transcripts per million (TPM) of fat and bile sensing receptors in MLN-Venus and negative cells, (BeD) Motilin secretion in response to indicated agonists (expressed as fold change versus basal condition measured in parallel). *p < 0.05, **p < 0.01, ***p < 0.001 by Welch's t-test, or Browne-Forsyth and Welch ANOVA with Dunnett's multiple comparisons (n ¼ 6e14 wells from 3 to 7 independent experiments), (E) Fura2 (340/380 nm) ratio in one representative MLN-Venus cell during perfusion of FFA1 agonist AM1638 (10 mM, pink), (F) Calcium signal across several cells, measured as fold change in maximal fura2 ratio, as in (E). ***p < 0.001 by one-sample test (n ¼ 77 cells from 7 independent experiments), (G) Action potentials evoked by incremental (þ2 pA) 500 ms current steps from 12 to 18 pA in the presence (blue) or absence (black) of GPBAR-A (3 mM). The dotted line at 0 mV represents the threshold used to count action potential spikes. The same axis scale is applied across all traces, and the current injection protocol applied is shown below voltage traces, (H) The number of action potentials recorded as in (G). *p < 0.05, **p < 0.01 by two-way ANOVA with Sidak's multiple comparisons (n ¼ 5 cells). Mean AE SEM presented.

Source publication
Article
Full-text available
Objective Motilin is a proximal small intestinal hormone with roles in gastrointestinal motility, gallbladder emptying and hunger initiation. In vivo motilin release is stimulated by fats, bile and duodenal acidification but the underlying molecular mechanisms of motilin secretion are poorly understood. This study aimed to establish the key signall...

Contexts in source publication

Context 1
... fat ingestion and gallbladder emptying stimulate motilin release in humans [16e18], we investigated the molecular mechanisms underlying M-cell sensing of bile and products of lipid digestion. Our RNA sequencing data demonstrated enriched expression of the G-protein bile acid receptor 1 (GPBAR1), long-chain fatty acid receptors, namely FFAR1 and FFAR4 (also known as FFA1/GPR40 and FFA4/GPR120, respectively), and the monoacylglycerol receptor GPR119 ( Figure 4A). As the endogenous ligands for these receptors are non-specific, we used selective synthetic ligands to study their function. ...
Context 2
... the endogenous ligands for these receptors are non-specific, we used selective synthetic ligands to study their function. Motilin secretion was significantly stimulated by the GPBAR1-agonist GPBAR-A (3 mM, 3.4-fold), the GPR119 agonist AR231453 (100 nM, 1.5-fold), and the FFA1 agonist AM1638 (10 mM, 2.4-fold) (Figure 4BeD). Even though there was a trend towards stimulated motilin secretion with the FFA4 agonist TUG891 at the higher concentration (30 mM) tested (1.3- fold; p ¼ 0.06), at this concentration it is known to also agonise FFA1 [34]. ...
Context 3
... though there was a trend towards stimulated motilin secretion with the FFA4 agonist TUG891 at the higher concentration (30 mM) tested (1.3- fold; p ¼ 0.06), at this concentration it is known to also agonise FFA1 [34]. Neither a lower concentration of TUG891 (1 mM), which should not activate FFA1, nor the FFA4-selective compound A [35] stimulated motilin secretion ( Figure 4D). This supports long-chain fatty acid signalling via FFA1 as a potent stimulus for motilin release. ...
Context 4
... gain further mechanistic insight into FFA1-and GPBAR1-dependent stimulation of motilin release, we measured intracellular calcium levels (after loading cells with fura2) or electrical activity of MLN-Venus cells in response to agonist application. Activation of the G q -coupled receptor FFA1 with AM1638 increased the calcium-dependent fura2 fluorescence ratio by >15% in 19/77 MLN-Venus cells (Figure 4EeF). Stimulation of the G s -coupled receptor GPBAR1 significantly increased the evoked action potential firing rate in MLN-Venus cells (Figure 4Ge H). ...
Context 5
... of the G q -coupled receptor FFA1 with AM1638 increased the calcium-dependent fura2 fluorescence ratio by >15% in 19/77 MLN-Venus cells (Figure 4EeF). Stimulation of the G s -coupled receptor GPBAR1 significantly increased the evoked action potential firing rate in MLN-Venus cells (Figure 4Ge H). A similar effect on evoked action potential firing rate was described for human ileal L-cells [20], which suggests a common mechanism of action of GPBAR1 on these two enteroendocrine cell types. ...
Context 6
... examined our RNA sequencing dataset to identify potential pHsensing mechanisms [38]. We found highly enriched expression in MLN-Venus cells of the acid-sensitive transient receptor potential channel TRPC4 [39] but inhibition of TRPC4 with ML204 did not alter motilin secretion ( Figure S4AeB). The two-pore potassium channels TALK1/KCNK16 and TASK1/KCNK3 were also enriched in M-cells ( Figure S4C), but would not account for the observed pH-dependent inward current, while known proton-sensing GPCRs were largely undetectable ( Figure S4D). ...
Context 7
... found highly enriched expression in MLN-Venus cells of the acid-sensitive transient receptor potential channel TRPC4 [39] but inhibition of TRPC4 with ML204 did not alter motilin secretion ( Figure S4AeB). The two-pore potassium channels TALK1/KCNK16 and TASK1/KCNK3 were also enriched in M-cells ( Figure S4C), but would not account for the observed pH-dependent inward current, while known proton-sensing GPCRs were largely undetectable ( Figure S4D). Several acid-sensing ion channels (ASIC1-4) were expressed in MLNVenus cells ( Figure 6A). ...
Context 8
... found highly enriched expression in MLN-Venus cells of the acid-sensitive transient receptor potential channel TRPC4 [39] but inhibition of TRPC4 with ML204 did not alter motilin secretion ( Figure S4AeB). The two-pore potassium channels TALK1/KCNK16 and TASK1/KCNK3 were also enriched in M-cells ( Figure S4C), but would not account for the observed pH-dependent inward current, while known proton-sensing GPCRs were largely undetectable ( Figure S4D). Several acid-sensing ion channels (ASIC1-4) were expressed in MLNVenus cells ( Figure 6A). ...

Citations

... The body regulates the biliary system through humoral hormones and other cytokines, including cholecystokinin (CCK), which stimulates gallbladder contraction and bile secretion, as well as GLP-2 and FGF19, which promote gallbladder relaxation (Choi et al., 2006;Yusta et al., 2017;Metry et al., 2023). The secretion of these hormones and signaling molecules is closely linked to bile acids in the gut (Hansen et al., 2020;Miedzybrodzka et al., 2021;Nerild et al., 2023). The diastole of the gallbladder ensures the normal excretion of bile salts, cholesterol and phospholipids from the liver cells in order to reduce the amount of cholesterol in the serum and tissues of the body; while the regular contraction of the gallbladder ensures the power of the bile flow in the biliary system and reduces the time of bile retention, thus decreasing the probability of gallstones occurrence. ...
Article
Full-text available
Common bile duct stones, as a type of cholelithiasis, are a benign biliary obstruction that easily acute abdominalgia, and Endoscopic Retrograde Cholangiopancreatography (ERCP) is usually the first choice for clinical treatment. However, the increasing recurrence rate of patients after treatment is troubling clinicians and patients. For the prevention of recurrence after ERCP, there is no guideline to provide a clear drug regimen, traditional Chinese medicine however has achieved some result in the treatment of liver-related diseases based on the “gut-liver-bile acid axis”. On the basis of this, this article discusses the possibility of traditional Chinese medicine to prevent common bile duct stones (CBDS) after ERCP, and we expect that this article will provide new ideas for the prevention of recurrence of CBDS and for the treatment of cholelithiasis-related diseases with traditional Chinese medicine in future clinical and scientific research.
... Following food ingestion, studies have reported that motilin levels are variously: increased by fat, decreased by glucose, either increased or decreased by protein or mixed meals, and increased by bile acids and duodenal acidification (4). In human duodenal organoids, stimuli of motilin release in vitro include fatty acids, bile acids and low pH (15). ...
... Most publications assessing motilin levels have employed a radioimmunoassay (RIA) (13), which appears reliable but is not commercially available, and like other antibody-based methods is potentially prone to antibody cross-reactivity. Liquid chromatography with tandem mass spectroscopy (LC-MS/MS) has proved capable of detecting motilin in human gastric and duodenal biopsies (8), and in supernatants from human duodenal organoids (15), raising the possibility of developing a quantitative LC-MS/MS method to assay motilin in human plasma. One published LC-MS/MS method for measuring motilin concentrations used rat plasma spiked with porcine motilin as the reference standard (16) but had selectivity and sensitivity problems with a detection limit of 10 ng mL -1 , considerably above the reported motilin levels measured in humans which are in the region of 0.2-0.5 ng mL -1 (13,17). ...
... On initiation of the study visit, participants continued to fast for 4 hours with blood samples being collected at 15 minute intervals. Immediately after collection of the 240 min sample, a standard mixed meal was ingested and blood samples taken at baseline just before the meal and at further time points (15,30,45, 60, 90, 120 min) after the meal. The mixed meal consisted of 237 mL Ensure plus, a balanced nutritional supplement containing 355 kcals (1497 kJ) including 12 g fat, 15 g protein and 48 g carbohydrate. ...
Article
Full-text available
Introduction Motilin is a hormone secreted by specialised enteroendocrine cells in the small intestine, and is known to modulate gastrointestinal motility in humans, regulating the migratory motor complex. It is understudied at least in part due to the lack of commercially available immunoassays. Method A multiplexed liquid chromatography mass spectrometry (LC-MS/MS) method was optimised to measure motilin, insulin, C-peptide, GIP (1–42) and GIP (3–42). Corresponding active ghrelin concentrations were determined by immunoassay. Ten healthy volunteers with no prior history of gastroenterological or endocrine condition attended after overnight fast and had blood samples taken every 15 minutes for 4 hours whilst continuing to fast, and then further sampling for 2 hours following a liquid mixed meal. Hunger scores were taken at each time point using a visual analogue scale. Normal bowel habit was confirmed by 1 week stool diary. Results Motilin levels fluctuated in the fasting state with an average period between peaks of 109.5 mins (SD:30.0), but with no evidence of a relationship with either ghrelin levels or hunger scores. The mixed meal interrupted cyclical motilin fluctuations, increased concentrations of motilin, insulin, C-peptide, GIP(1-42) and GIP(3-42), and suppressed ghrelin levels. Discussion This study highlights the utility of LC-MS/MS for parallel measurement of motilin alongside other peptide hormones, and supports previous reports of the cyclical nature of motilin levels in the fasting state and interruption with feeding. This analytical method has utility for further clinical studies into motilin and gut hormone physiology in human volunteers.
... Among macronutrients, lipids, such as triglycerides, are known to have contradictory effects on GI motility. Miedzybrodzka et al. (2021) reported that the long-chain fatty acid receptor FFA1 and the monoacylglycerol receptor GPR119 stimulated MLN secretion. However, a chronic high-fat diet increases glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion (Wang et al., 2015). ...
Article
Full-text available
Introduction: Motilin (MLN) is a gastrointestinal (GI) hormone produced in the upper small intestine. Its most well understood function is to participate in Phase III of the migrating myoelectric complex component of GI motility. Changes in MLN availability are associated with GI diseases such as gastroesophageal reflux disease and functional dyspepsia. Furthermore, herbal medicines have been used for several years to treat various GI disorders. We systematically reviewed clinical and animal studies on how herbal medicine affects the modulation of MLN and subsequently brings the therapeutic effects mainly focused on GI function. Methods: We searched the PubMed, Embase, Cochrane, and Web of Science databases to collect all articles published until 30 July 2023, that reported the measurement of plasma MLN levels in human randomized controlled trials and in vivo herbal medicine studies. The collected characteristics of the articles included the name and ingredients of the herbal medicine, physiological and symptomatic changes after administering the herbal medicine, changes in plasma MLN levels, key findings, and mechanisms of action. The frequency patterns (FPs) of botanical drug use and their correlations were investigated using an FP growth algorithm. Results: Nine clinical studies with 1,308 participants and 20 animal studies were included in the final analyses. Herbal medicines in clinical studies have shown therapeutic effects in association with increased levels of MLN, including GI motility regulation and symptom improvement. Herbal medicines have also shown anti-stress, anti-tumor, and anti-inflammatory effects in vivo . Various biochemical markers may correlate with MLN levels. Markers may have a positive correlation with plasma MLN levels included ghrelin, acetylcholine, and secretin, whereas a negative correlation included triglycerides and prostaglandin E 2 . Markers, such as gastrin and somatostatin, did not show any correlation with plasma MLN levels. Based on the FP growth algorithm, Glycyrrhiza uralensis and Paeonia japonica were the most frequently used species. Conclusion: Herbal medicine may have therapeutic effects mainly on GI symptoms with involvement of MLN regulation and may be considered as an alternative option for the treatment of GI diseases. Further studies with more solid evidence are needed to confirm the efficacy and mechanisms of action of herbal medicines. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=443244 , identifier CRD42023443244.
... It acts on gastrointestinal smooth muscle and intestinal nervous system, playing a role in gastrointestinal motility (Kitazawa and Kaiya, 2021;Tack et al., 2021), and is involved in various gastrointestinal diseases ( Van den Houte et al., 2020;Wang T. et al., 2020;Ko et al., 2021;Zhang et al., 2021). MTL binds to MTL receptors (MTLRs) that are located primarily in the enteric nerves, smooth muscle, and gastric vagal nerve terminals of the gastrointestinal (GI) tract (Kitazawa and Kaiya, 2021;Li et al., 2021;Miedzybrodzka et al., 2021). MTL is involved in regulating gastric motility through the vagus nerve (Sanger et al., 2009;Liu et al., 2010;Javid et al., 2013). ...
Article
Full-text available
Aims To observe the effects of intrathecal administration of motilin on pain behavior and expression of motilin (MTL)/motilin receptor (MTLR) in the spinal cord of a rat model of acute incisional pain. Methods An incisional pain model was established in rats using a unilateral plantar incision. The rats were also injected intrathecally with 1, 5, or 25 μg of motilin. The mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) were determined. MTL/MTLR expression in the spinal cord was detected by western blotting and immunofluorescence. The expression of MTL in the spinal cord, stomach, duodenum, and plasma was determined by enzyme-linked immunosorbent assay (ELISA). Results Motilin/motilin receptor were detected in the spinal cord. Spinal cord MTL/MTLR expression peaks at 2 h after modeling (P < 0.05) and start to decrease at 24 h (P < 0.05) to almost reach baseline levels at 72 h. The changes in gastric, duodenal, plasma, and spinal cord motilin levels correlated with MWT and TWL (all R² > 0.82). The intrathecal injection of 1, 5, or 25 μg of motilin could increase the pain threshold of rats with incisional pain within 72 h in a dose-dependent manner. Conclusion This study showed for the first time that MTL/MTLR are expressed in rats’ spinal dorsal horn. Acute pain increased MTL/MTLR expression in the spinal dorsal horn. Also, for the first time, this study showed that motilin intrathecal injection alleviates pain in rat models of acute incisional pain. These results suggest that MTL/MTLR could be a novel target for the management of acute pain.
Article
Motilin is an important hormonal regulator in the migrating motor complex (MMC). Free fatty acid receptor-1 (FFAR1, also known as GPR40) has been reported to stimulate motilin release in human duodenal organoids. However, how FFAR1 regulates gastric motility in vivo is unclear. This study investigated the role of FFAR1 in the regulation of gastric contractions and its possible mechanism of action using Suncus murinus. Firstly, intragastric administration of oleic acid (C18:1, OA), a natural ligand for FFAR1, stimulated phase II-like contractions, followed by phase III-like contractions in the fasted state, and the gastric emptying rate was accelerated. The administration of GW1100, an FFAR1 antagonist, inhibited the effects of OA-induced gastric contractions. Intravenous infusion of a ghrelin receptor antagonist (DLS) or serotonin 4 (5-HT4) receptor antagonist (GR125487) inhibited phase II-like contractions and prolonged the onset of phase III-like contractions induced by OA. MA-2029, a motilin receptor antagonist, delayed the occurrence of phase III-like contractions. In vagotomized suncus, OA did not induce phase II-like contractions. In addition, OA promoted gastric emptying through a vagal pathway during the postprandial period. However, OA did not directly act on the gastric body to induce contractions in vitro. In summary, this study indicates that ghrelin, motilin, 5-HT, and the vagus nerve are involved in the role of FFAR1 regulating MMC. Our findings provide novel evidence for the involvement of nutritional factors in the regulation of gastric motility.
Article
The hormone cholecystokinin (CCK) is secreted postprandially from duodenal enteroendocrine cells and circulates in the low picomolar range. Detection of this digestion and appetite-regulating hormone currently relies on the use of immunoassays, many of which suffer from insufficient sensitivity in the physiological range and cross-reactivity problems with gastrin, which circulates at higher plasma concentrations. As an alternative to existing techniques, a liquid chromatography and mass spectrometry-based method was developed to measure CCK-derived peptides in cell culture supernatants. The method was initially applied to organoid studies and was capable of detecting both CCK8 and an N-terminal peptide fragment (prepro) ppCCK(21-44) in supernatants following stimulation. Extraction optimization was performed using statistical modeling software, enabling a quantitative LC-MS/MS method for ppCCK(21-44) capable of detecting this peptide in the low pM range in human plasma and secretion buffer solutions. Plasma samples from healthy individuals receiving a standardized meal (Ensure) after an overnight fast were analyzed; however, the method only had sensitivity to detect ppCCK(21-44). Secretion studies employing human intestinal organoids and meal studies in healthy volunteers confirmed that ppCCK(21-44) is a suitable surrogate analyte for measuring the release of CCK in vitro and in vivo.
Article
Full-text available
Enteroendocrine cells are specialized secretory lineage cells in the small and large intestines that secrete hormones and peptides in response to luminal contents. The various hormones and peptides can act upon neighboring cells and as part of the endocrine system, circulate systemically via immune cells and the enteric nervous system. Locally, enteroendocrine cells have a major role in gastrointestinal motility, nutrient sensing, and glucose metabolism. Targeting the intestinal enteroendocrine cells or mimicking hormone secretion has been an important field of study in obesity and other metabolic diseases. Studies on the importance of these cells in inflammatory and auto-immune diseases have only recently been reported. The rapid global increase in metabolic and inflammatory diseases suggests that increased understanding and novel therapies are needed. This review will focus on the association between enteroendocrine changes and metabolic and inflammatory disease progression and conclude with the future of enteroendocrine cells as potential druggable targets.
Article
This study aimed to investigate the amendatory effects of Fu brick tea aqueous extract (FTE) on constipation and its underlying molecular mechanism. The administration of FTE by oral gavage (100 and 400 mg/kg·bw) for 5 weeks significantly increased fecal water content, improved difficult defecation, and enhanced intestinal propulsion in loperamide (LOP)-induced constipated mice. FTE also reduced colonic inflammatory factors, maintained the intestinal tight junction structure, and inhibited colonic Aquaporins (AQPs) expression, thus normalizing the intestinal barrier and colonic water transport system of constipated mice. 16S rRNA gene sequence analysis results indicated that two doses of FTE increased the Firmicutes/Bacteroidota (F/B) ratio at the phylum level and increased the relative abundance of Lactobacillus from 5.6 ± 1.3 to 21.5 ± 3.4% and 28.5 ± 4.3% at the genus level, subsequently resulting in a significant elevation of colonic contents short-chain fatty acids levels. The metabolomic analysis demonstrated that FTE improved levels of 25 metabolites associated with constipation. These findings suggest that Fu brick tea has the potential to alleviate constipation by regulating gut microbiota and its metabolites, thereby improving the intestinal barrier and AQPs-mediated water transport system in mice.
Article
Motilin is a gastrointestinal hormone secreted by the duodenum. This peptide regulates a characteristic gastrointestinal contraction pattern, called the migrating motor complex, during the fasting state. Motilin also affects the pressure of the lower esophageal sphincter, gastric motility and gastric accommodation in the gastrointestinal tract. Furthermore, motilin induces bile discharge into the duodenum by promoting gallbladder contraction, pepsin secretion in the stomach, pancreatic juice and insulin secretion from the pancreas. In recent years, it has been shown that motilin is associated with appetite, and clinical applications are expected for diseases affected by food intake, e.g. obesity, by regulating motilin levels. Gastric acid and bile are the two major physiological regulators for motilin release. Caloric foods have varying effects on motilin levels, depending on their composition. Among non-caloric foods, bitter substances reduce motilin levels and are therefore expected to have an appetite-suppressing effect. Various motilin receptor agonists and antagonists have been developed but have yet to reach clinical use.
Article
Motilin, a peptide hormone consisting of 22 amino acid residues, was identified in the duodenum of pigs in the 1970s. It is known to induce gastrointestinal contractions during the interdigestive state in mammals. Although the motilin gene has been identified in various animal species, it has not been studied in amphibians. Here, we identified the motilin gene in the Japanese fire bellied newt (Cynops pyrrhogaster), and conducted an analysis of tissue distribution, morphological observations, and physiological experiments. The deduced mature newt motilin comprises 22 amino acid residues, like in mammals and birds. The C-terminus of the newt motilin showed high homology with motilin from other species compared to the N-terminus region, which is considered the bioactive site. Motilin mRNA expression in newts was abundant in the upper small intestine, with notably high motilin mRNA expression found in the pancreas. Motilin-producing cells were found in the mucosal layer of the upper small intestine and existed as two cell types: open-and closed-type cells. Motilin-producing cells in the pancreas were also found to produce insulin but not glucagon. Newt motilin stimulated gastric contractions but not in other parts of the intestines in vitro, and motilin-induced gastric contraction was significantly inhibited by treatment with atropine, a muscarinic acetylcholine receptor antagonist. These results indicate that motilin is also present in amphibians, and that its gastrointestinal contractile effects are conserved in mammals, birds, and amphibians. Additionally, we demonstrated for the first time the existence of pancreatic motilin, suggesting that newt motilin has an additional unknown physiological role.